(2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2)(CAS: 661464-94-4)
![(2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2) (2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2)](https://cnstatic.chemtradehub.com/structs/661/661464-94-4-f23b.webp)
CAS号
相关产品
其他供应商提供的 (2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2)
基本信息
分子式
C30H48N2O12
分子量
628.72 g/mol
化学标识符
SMILES
CC(C)(C)NC[C@@H](c1ccc(c(c1)CO)O)O.CC(C)(C)NC[C@@H](c1ccc(c(c1)CO)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
InChIKey
VNVNZKCCDVFGAP-FPDJQMMJSA-N
数据库引用
MDL号
MFCD08067729
常见问题
左旋沙丁胺醇酒石酸盐适用于《全球化学品统一分类和标签制度》(GHS),以及《欧盟化学品注册、评估、授权和限制法规》(REACH)。此外,该化合物还需遵循《美国食品药品监督管理局》(FDA)和《美国环保署》(EPA)的相关规定。
左旋沙丁胺醇酒石酸盐的替代品包括盐酸沙丁胺醇和其他β2肾上腺素受体激动剂,如丙卡特罗。这些替代品在合成过程中可作为左旋沙丁胺醇酒石酸盐的替代选择,具体选择取决于实际应用需求和成本考虑。
市场趋势方面,左旋沙丁胺醇酒石酸盐因其在哮喘和慢性阻塞性肺疾病治疗中的应用而保持稳定增长。研究趋势则侧重于其在新型药物制剂、递送系统方面的应用研究,以及与其他药物联用的可能性。
含有左旋沙丁胺醇酒石酸盐的废料应先冷却至室温,然后使用活性炭或树脂进行吸附处理。吸附后的废液应在专业处理设施中进行焚烧处理,或者采用其他专业废弃处理方法,确保符合环保标准。在处理过程中,应严格遵守相关法规和安全操作规程。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
联系人
李经理
邮箱
caokunli@163.com

![6-{[(2R)-2-Methyl-1,4-diazocan-1-yl]sulfonyl}isoquinoline](https://cnstatic.chemtradehub.com/structs/125/1258833-31-6-446c.webp)
![N-({2-[2-(2-Aminoethoxy)ethoxy]ethoxy}acetyl)-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide hydrochloride (1:1)](https://cnstatic.chemtradehub.com/structs/209/2097971-11-2-2381.webp)

![N-(14-Amino-3,6,9,12-tetraoxatetradec-1-yl)-6-[(4R,5S)-5-methyl-2-oxo-4-imidazolidinyl]hexanamide](https://cnstatic.chemtradehub.com/structs/230/2306109-91-9-4482.webp)
![(3S,3aR,5aR,5bS,7aS,10R,11R,11aS,13aS,13bR)-11-Hydroxy-1,3-bis(hydroxymethyl)-3,5a,5b,10,11,13b-hexamethyl-3,3a,4,5,5a,5b,6,7,8,9,10,11,11a,13,13a,13b-hexadecahydro-7aH-cyclopenta[a]chrysene-7a-carbox
ylic acid](https://cnstatic.chemtradehub.com/structs/214/214285-76-4-78e7.webp)

![4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one](https://cnstatic.chemtradehub.com/structs/152/152-72-7-8795.webp)

carbamoyl}amino)-4-(4-morpholinyl)butanoyl]amino}-1,6-diphenyl-2-hexanyl]carbamate](https://cnstatic.chemtradehub.com/structs/100/1004316-88-4-654e.webp)
![(2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2) — 湖北广奥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecc352b2de6e8e95a5c3b/67cecc352b2de6e8e95a5c3b-logo.webp)
![(2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2) — 湖北实顺生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecc092b2de6e8e95a5bbc/67cecc092b2de6e8e95a5bbc-logo.webp)
![(2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2) — 上海绩祥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)
![(2R,3R)-2,3-Dihydroxysuccinic acid - 2-(hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol (1:2) — 湖北诺纳科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce946e2b2de6e8e95a4840/67ce946e2b2de6e8e95a4840-logo.webp)